Metabolomics of a cell line-derived xenograft model reveals circulating metabolic signatures for malignant mesothelioma

BACKGROUND: Malignant mesothelioma (MM) is a rare and highly aggressive cancer. Despite advances in multidisciplinary treatments for cancer, the prognosis for MM remains poor with no effective diagnostic biomarkers currently available. The aim of this study was to identify plasma metabolic biomarker...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Yun, Dai, Ziyi, Yang, Chenxi, Wang, Ding, Guo, Zhenying, Mao, Weimin, Chen, Zhongjian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2022
Materias:
Biochemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740518/
https://www.ncbi.nlm.nih.gov/pubmed/35036082
http://dx.doi.org/10.7717/peerj.12568

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740518/
https://www.ncbi.nlm.nih.gov/pubmed/35036082
http://dx.doi.org/10.7717/peerj.12568

Ejemplares similares